THE DEAL: Two generic drugmakers will pay $2.15 billion to Pfizer Inc. and Takeda Pharmaceuticals to resolve a lawsuit over the heartburn drug Protonix.
THE LAUNCH: Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. started selling generic versions of Protonix before the patents supporting the drug expired. They hoped to get those patents overturned or reach a settlement that would allow them to start selling their versions before the patents expired.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.